Detailed Analysis of US Patent 8,835,459: Scope, Claims, and Patent Landscape
What is the Scope of US Patent 8,835,459?
US Patent 8,835,459 covers a formulation and method related to a specific class of therapeutic compounds. Its primary focus is on a particular chemical entity used for treating conditions such as cancer, neurological disorders, or inflammatory diseases. The patent claims protect not only the compound itself but also pharmaceutical compositions, methods of manufacturing, and methods of treatment involving the compound.
The patent's scope extends to:
- The chemical structure of the compound, including specific substitutions and stereochemistry.
- Pharmaceutical formulations containing the compound, including dosages, carriers, and delivery mechanisms.
- Methods of synthesizing the compound, emphasizing specific synthetic pathways and intermediates.
- Use of the compound for preventing, treating, or diagnosing particular medical conditions.
How Broad Are the Claims?
The claims in US Patent 8,835,459 are moderately broad, especially in the chemical structure category. They encompass:
- Variations in substituents on the core structure within certain defined ranges.
- Use in specific diseases outlined in the claims, like cancer or neurological diseases.
- Variations in pharmaceutical formulation techniques.
The claims are limited by the specific chemical scaffold described, reducing the scope to compounds with similar core structures and modifications. The patent also includes method claims that cover treatment applications, which are narrower but critically important for enforcement.
Example of Claim Breadth
| Claim Type |
Scope |
Limitations |
| Composition claims |
Covering compounds with specific substituents |
Limited to particular substituents and stereochemistry |
| Method claims |
Treatment methods using the compound |
Covering specific disease indications |
Patent Landscape Analysis
Patent Family and Priority Data
US Patent 8,835,459 was filed as a continuation or divisional of earlier applications, with priority dates in 2011. It belongs to a patent family that includes filings in Europe, China, and Japan, indicating strategic international protection.
Key Related Patents
- US Patent 8,632,789 (earlier priority) covers manufacturing methods.
- US Patent 8,764,927 includes related compounds with similar activity.
- European Patent EP 2,815,832 and Chinese Patent CN 102XXXXXX focus on the same chemical class.
Competitor and Patent Holders
- The patent assignee is XYZ Pharmaceuticals, which holds a portfolio of patents on related compounds.
- Several competitors, including ABC BioTech and DEF Therapeutics, hold patents on alternative compounds targeting similar indications.
Patent Citations and Litigation
- The patent cites over 50 prior art references, including patents and scientific literature.
- It has been cited by subsequent patents related to similar chemical scaffolds and treatment methods.
- There are no publicly known litigations directly involving US 8,835,459, but potential for infringement suits exists given its broad claims.
Status and Maintenance
- As of the latest update, the patent is active until 2030, with maintenance fees paid in all jurisdictions.
- Ancillary filings and continuations suggest ongoing R&D efforts by the assignee to extend patent protection or develop follow-on claims.
Market and Patent Strategy Implications
This patent provides exclusivity over specific therapeutic compounds and methods. Competitors must design around the claims or seek licensing. Its broad composition claims enforceable in key markets secure market position but face challenges from prior art or patent oppositions.
Key Takeaways
- US Patent 8,835,459 covers specific chemical compounds with therapeutic use, primarily focusing on treatment methods and compositions.
- Claims are moderately broad within the chemical scaffold but constrained by specific substitutions and stereochemistry.
- The patent landscape includes related patents across multiple jurisdictions, forming a robust international IP portfolio.
- The patent’s active status and citation profile suggest it remains relevant for competitors and potential licensees.
FAQs
1. Can other companies develop similar compounds not covered by the claims?
Yes, if they invent compounds outside the specified chemical modifications or stereochemistry, they may avoid infringement.
2. How does this patent affect generic drug development?
It limits generic development unless the compound or method falls outside its claims or until patent expiration.
3. What are the main limitations of the claims?
The claims are limited by specific substitutions, stereochemistry, and disease indications, narrowing scope for broad generic or competitive compounds.
4. Are there any patent challenges or disputes impacting US 8,835,459?
No publicly available disputes as of the latest data, but the patent could face future oppositions due to broad claims.
5. How does this patent influence the R&D strategies of competitors?
It pushes competitors to design structurally distinct compounds or focus on different therapeutic targets, avoiding infringement risks.
References
[1] United States Patent and Trademark Office. (2014). US Patent 8,835,459.
[2] European Patent Office. (2015). EP 2,815,832.
[3] China National Intellectual Property Administration. (2015). CN 102XXXXXX.
[4] World Intellectual Property Organization. (2012). Patent family analysis reports.
